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Case Report
Spontaneous Cardiac Hypertrophy in a Crl:CD(SD) Rat
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Abstract:  Cardiac hypertrophy was observed in a 9-week-old Crl:CD(SD) rat that died unexpectedly.  The animal was
allocated to the control group of a toxicity study, and no abnormalities in its general conditions, body weight or food
intake were observed.  Necropsy revealed an increase in heart weight.  Gross examination indicated cardiac enlargement
with thickening of the right and left ventricular walls.  Histopathological examination revealed hypertrophy of the
cardiomyocytes in the right and left ventricular walls and the interventricular septum.  Electron microscopic examination
indicated bizarre nuclei and accumulation of an increased number of various sizes of mitochondria in the perinuclear
region of the hypertrophied myocytes.  Hypertrophied myocytes connected by intensely folded intercalated disks were
also observed.  Based on these findings, the animal was diagnosed with cardiac hypertrophy.  This is the first case report
of cardiac hypertrophy in this strain.   (J Toxicol Pathol 2009; 22: 83–87)
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Cardiac hypertrophy is cellular adaptation of the heart
in response to pressure or volume overload that results from
hypertension and cardiovascular malformations such as
ventricular septal defect (VSD) and valvular heart disease.
Cardiac hypertrophy has been reported in several rat
models1–5.  For example, cardiac hypertrophy has been
experimentally induced in Dahl salt-sensitive rats and rats
with constricted aortas.  Untreated spontaneously
hypertensive rats (SHR) and Wistar Kyoto (WKY) rats also
develop cardiac hypertrophy.  Increased heart weights and
thickening of the ventricular wall have been observed in
these rats.
Crl:CD(SD) (SD) rats have been used increasingly in
recent toxicity studies, and background data on these rats
have been collected.  However, few cases of spontaneous
cardiac hypertrophy have been reported in this strain.
Herein, we describe a case of spontaneous cardiac
hypertrophy in a 9-week-old SD rat that died unexpectedly.
This male SD rat was obtained from Charles River
Laboratories Japan, Inc. (Kanagawa, Japan) at 5 weeks of
age and was handled in accordance with the guidelines for
the care and use of laboratory animals established by the
Ethical Committee for Animal Experiments of Yakult
Central Institute.  After an acclimation period of 1 week, the
rat was allocated to the control group of a 4-week repeated
dose toxicity study, and distilled water was orally
administered to the rat daily.  However, the rat died
unexpectedly on day 22.  During the study, no abnormalities
were observed in its general conditions, body weight or food
intake.  Necropsy revealed cardiac enlargement (Fig. 1a) and
an increase in heart weight (Table 1)6.  Thickening of the
right (RV) and left ventricular (LV) walls and slight
enlargement of both ventricular cavities were observed in a
cross section of the heart (Fig. 1b).  The thickening was more
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Table 1. Absolute and Relative Organ Weights of the 9-Week-Old
SD Rat that Developed Spontaneous Cardiac Hypertrophy
(Present Case) and 9-Week-Old Normal SD Rats.
Organ Present case* Normal rats
Mean ± SD (n = 30)
Final body weight (g) 339.0 347.0 ± 18.2
Heart (g) 2.724 1.19 ± 0.09
(g%) 0.804 0.34 ± 0.02
Lung (g) 1.832 1.23 ± 0.07
(g%) 0.540 0.36 ± 0.02
Liver (g) 19.394 10.63 ± 1.07
(g%) 5.721 3.06 ± 0.19
Spleen (g) 0.923 0.70 ± 0.08
(g%) 0.272 0.20 ± 0.02
Kidney (R) (g) 1.755 1.35 ± 0.11
(g%) 0.518 0.39 ± 0.03
Kidney (L) (g) 1.719 1.34 ± 0.11
(g%) 0.507 0.39 ± 0.03
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prominent in the right ventricle.  After fixation, the rat’s lung
was pale yellow.  No abnormal changes were observed in
other organs.  The heart and other organs were routinely
fixed in 10% phosphate-buffered formalin solution,
embedded in paraffin, sectioned and stained with
hematoxylin and eosin (HE) or using Masson’s trichrome
techniques.  Immunohistochemical staining for proliferating
cell nuclear antigen (PCNA; DAKO, Denmark) or ED1
(Serotec, United Kingdom) was performed using the labeled
streptavidin-biotin method.  To evaluate cardiomyocyte
Fig. 1. Gross appearance of cardiac hypertrophy in the 9-week-old SD rat (present case, H).  Cardiac enlargement and thickening of the right and
left ventricular walls compared with a 10-week old normal SD rat (N) are observed in the (a) whole heart and (b) transverse sections of the
heart.
Fig. 2. Cross sections of the heart (present case, a–d) of the 9-week-old SD rat that developed spontaneous cardiac hypertrophy and (e–h) of a 10-
week-old normal SD rat.  Hypertrophy of the myocytes can be seen in the (b) right ventricular (RV) wall, (c) interventricular septum
(IVS) and (d) left ventricular (LV) wall.  Normal myocytes can be seen in the (f) RV wall, (g) IVS and (h) LV wall.  HE staining.  b, c, d,
f, g, and h: ×400.Suzuki, Kado, Ando et al. 85
hypertrophy, the short diameters of the cardiomyocytes were
measured in 3 areas (outer layer, inner layer and middle
layer) of the RV and LV walls or the interventricular septum
(IVS) in HE-stained sections.  The short diameters of
cardiomyocytes were measured across the nuclei, and 30
cells were counted histologically in each area.  For electron
microscopic examination, small pieces of the formalin-fixed
right ventricle of the heart were first immersed in phosphate-
buffered 2.5% glutaraldehyde and then in phosphate-
buffered 1% osmium tetroxide for 2 h each.  After
dehydration through a graded ethanol series, the tissue
samples were embedded in Epon 812 resin.  Ultrathin
sections were prepared and stained with uranyl acetate and
lead citrate and then observed under a transmission electron
microscope (JEM-1200EX; JEOL, Tokyo, Japan).
Histopathological examination indicated cardiomyocyte
hypertrophy in the RV and LV walls and IVS.  The
cardiomyocyte diameter indicated that hypertrophy was
most prominent in the RV wall (Figs. 2 and 3).
Hypertrophied myocytes had large nuclei, some of which
were positive for PCNA.  This suggested that
cardiomyocytes would be occurred polyploidization7–9.
Cardiomyocyte hypertrophy, myocardial degeneration,
infiltration of mononuclear cells (histiocytes: positive for
ED1) and interstitial/perivascular fibrosis (stained blue by
Masson’s trichrome) were also observed in the IVS of the
heart (Fig. 4).  In addition, disarray of cardiomyocytes was
observed at the junction of the IVS and ventricular walls.
Furthermore, cellular infiltration of the subepicardium was
observed.  In the lungs, slight increases in collagen fiber at
the alveolar lesion and macrophages containing hemosiderin
(heart failure cells) in the alveolar lumen were observed.
These findings indicated that pulmonary congestion was a
secondary change caused by heart failure due to cardiac
hypertrophy.  No abnormal histological changes were
observed except in the heart and lungs.  Electron
microscopic examination identified bizarre nuclei in
hypertrophied myocytes and accumulation of an increased
number of various sizes of mitochondria in the cytoplasm of
the hypertrophied myocytes in the perinuclear region.
Hypertrophied myocytes connected by intensely folded
intercalated disks were also observed (Fig. 5).
SHR and WKY rats are known to spontaneously
develop cardiac hypertrophy.  SHR rats develop cardiac
hypertrophy in response to hypertension, and LV
hypertrophy is characteristic of this strain.  In addition to
these changes in the heart, periarteritis nodosa in mesenteric
and pancreatic arteries; fibrinoid deposition in medium and
small renal arteries; and arteriolar infarction of the kidney,
Fig. 3. Comparison of the short diameters of hypertrophic
cardiomyocytes with those in a 10-week-old normal SD rat.
The cardiomyocytes of the rat with cardiac hypertrophy are
significantly larger in all layers, except for the middle
interventricular septum (IVS) layer.  *: p < 0.05, **: p < 0.01,
***: p < 0.001.  RV, right ventricular wall; LV, left
ventricular wall.
Fig. 4. (a) Myocardial degeneration, (b) infiltration of mononuclear cells and (c) interstitial/perivascular fibrosis at the interventricular septum
(IVS) of the hypertrophic heart.  a: HE staining, ×100; b: HE staining, ×400; c: Masson’s trichrome, ×400.86 Cardiac Hypertrophy in an SD Rat
testis and brain have been reported in SHR rats4.
Generalized edema, pleural effusion, ascites, congestion of
the lung and liver and nephrosclerosis have also been
reported in SHR rats.  On the other hand, normotensive
WKY rats develop cardiac hypertrophy because of
cardiovascular malformations, such as VSD, and LV and
biventricular hypertrophy are characteristic in this strain5,10.
In the present case, cardiac changes, increase in heart weight,
cardiac enlargement, thickening of the ventricular walls and
cardiomyocyte hypertrophy were observed that were similar
to those observed in SHR and WKY rats.  Pulmonary
congestion was also observed in the present case.  However,
there were no obvious changes in other organs and tissues.
In the present case, the cause of hypertrophy was unknown;
however, (1) the rat had biventricular hypertrophy, (2) no
obvious changes in the blood vessels of the kidney or the
brain indicating hypertension were observed, (3) the rat died
relatively young (at 9 weeks of age) and (4) Crl:CD(SD) rats
Fig. 5. Electron microscopic findings of cardiomyocytes obtained from the SD rat that developed spontaneous cardiac hypertrophy.  (a) Various
sizes of mitochondria and an increase in the number of mitochondria in the cytoplasm, (b) bizarre nuclei and (c) an intensely folded
intercalated disk connecting two adjacent myocytes can be seen.  (d–f) Cardiomyocytes from a 10-week-old normal SD rat.Suzuki, Kado, Ando et al. 87
have been known to develop congenital anomalies of the
heart11.  Thus, it is possible that the cardiac hypertrophy in
this rat could have resulted from cardiovascular
malformation or valvular heart disease.
In the present case, the main finding in the heart was
cardiomyocyte hypertrophy, although myocardial
degeneration, infiltration of histiocytes and fibrosis were
also observed at the IVS.  Furthermore, the electron
microscopic findings reflected the fact that the myocardial
hypertrophy of the present case had progressed to a stage of
adaptation or compensated hyperfunction.  Based on these
findings, the SD rat that died unexpectedly at 9-weeks old
was diagnosed with cardiac hypertrophy.
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